Benjamin Albert files Form 144 to sell HCAT shares
Benjamin Albert submitted a Form 144 reporting an intended sale of restricted common stock of Health Catalyst, Inc. on 03/02/2026.
Rhea-AI Filing Summary
Benjamin Albert submitted a Form 144 reporting an intended sale of restricted common stock of Health Catalyst, Inc. on 03/02/2026. The filing lists 4,966 shares in connection with broker Morgan Stanley Smith Barney LLC and shows a prior sale of 13,304 shares on 02/26/2026.
Positive
- None.
Negative
- None.
Insights
Form 144 notifies an intended insider sale; reporting details and recent sales are disclosed.
The filing lists an intended sale of restricted common stock of Health Catalyst, Inc. dated 03/02/2026 with 4,966 shares tied to Morgan Stanley Smith Barney LLC. It also records a sale of 13,304 shares on 02/26/2026.
These disclosures meet routine reporting obligations under resale rules; actual execution, settlement, and any proceeds are determined by subsequent transactions and are not shown in the excerpt.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Who filed the Form 144 for HCAT?
Were there recent HCAT sales by the same filer?
Which broker is named in the Form 144 for HCAT transactions?
Does the Form 144 show proceeds or execution status for the sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.